Marta Ribelli
Marta Ribelli publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research and Lung Cancer Treatments and Mutations.
- World rank
- #4,276,443 of 7,710,434 ranked researchers
- Rank in Italy
- #144,836 of 242,206
- Works
- 31
- Citations
- 232
- Citations per work
- 7.5
What does Marta Ribelli research?
Marta Ribelli's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (13%), Economics, Econometrics and Finance (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2477.5%
- Medicine2477.5%
- Life Sciences413.0%
- Everything else26.3%
- Social Sciences13.2%
- 1Oncology48% of their works
- 2Pulmonary and Respiratory Medicine23% of their works
- 3Molecular Biology6% of their works
- 4Hepatology6% of their works
- 5Cancer Research6% of their works
- 6Economics and Econometrics3% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Treatments and Mutations
- Cancer Genomics and Diagnostics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Gastric Cancer Management and Outcomes
Which keywords describe Marta Ribelli's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Targeted Therapy, Tumor Microenvironment, Clinical Practice Guidelines, ALK Inhibitors and EGFR Mutations.
- Taxanes
- Immune Checkpoint Blockade
- Endoscopic Resection
- Mutational Signatures
- Hepatocellular Carcinoma
- Surgical Complications
- EGFR Mutations
- Clinical Practice Guidelines
- Targeted Therapy
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Tumor Microenvironment
- ALK Inhibitors
- Pancreatic Cancer
- Cancer Genomics
- Liver Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Gastric Cancer
- PD-1 and PD-L1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy323 topics
- Cetuximab191 topic
- KRAS Mutations191 topic
- Targeted Therapy142 topics
- Tumor Microenvironment132 topics
- Clinical Practice Guidelines112 topics
- ALK Inhibitors81 topic
- EGFR Mutations81 topic
- Pancreatic Cancer81 topic
- Surgical Complications81 topic
- Cancer Genomics61 topic
- Hepatocellular Carcinoma61 topic
- Liver Cancer61 topic
- Mutational Signatures61 topic
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Endoscopic Resection51 topic
- Gastric Cancer51 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
- Taxanes51 topic
Where does Marta Ribelli work?
Marta Ribelli's main affiliation in the publication record is Agostino Gemelli University Polyclinic, Italy.
How many publications and citations does Marta Ribelli have?
OpenAlex counts 31 works and 232 citations for Marta Ribelli, an h-index of 7, ranking #4,276,443 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marta Ribelli. Posts are plain text and can be reported.